EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

FGF19 and muscle architecture in older patients

Emilie Bres, Julia Bouvier, Aymeric Courtay, Léo Delaire, Joannes Humblot, Charlotte Cuerq, Stéphanie Tripoz-Dit-Masson, Mathieu Fauvernier, Thomas Gilbert, Marc Bonnefoy

Experimental Gerontology · 2023

DOI: 10.1016/j.exger.2023.112120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Gerontology, 2023. Verfasst von Emilie Bres und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gerontology, Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France. Electronic address: Emilie.bres@chu-lyon.fr. Hauptthemen laut MEDLINE: Frailty, Sarcopenia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Sarcopenia has a significant medical and economic impact. Serum fibroblast growth factor 19 (FGF19) has recently been described as promoting muscle mass and strength, and could be an interesting marker for early diagnosis of sarcopenia and prevention of its consequences. Ultrasound is a robust non-invasive technique used to measure muscle parameters, which cannot be evaluated by usual body composition measures, but are known to be associated with muscle function. In this cross-sectional cohort study, we aimed to determine whether FGF19 levels were correlated with functional muscle tests and muscle ultrasound parameters. METHODS: Patients over 70 years old with a mobility disability risk were recruited from the cohort of the "well on your feet" mobility loss prevention program. Sarcopenia was diagnosed according to the European Working Group on Sarcopenia in Older Patients 2 (EWGSOP2) criteria. We have performed functional battery tests, muscle ultrasound measures and bioimpedance spectroscopy. FGF19 levels were measured by the ELISA method. RESULTS: Out of 52 patients involved (34 women, mean age 81.3 years), 30 patients were sarcopenic (15 patients with probable sarcopenia and 15 with certain sarcopenia). Sarcopenic patients were older (mean 82.8 versus 79.6 years, P = 0.033), with higher frailty Fried score (P = 0.006), lower IADL score (P = 0.008), had lower daily protein intakes (P = 0.023) and were less performant to muscle functional tests than non-sarcopenic patients. Serum FGF19 levels were negatively correlated with the SPPB score (rs = 0.28; P = 0.045). FGF19 levels were correlated positively with the pennation angle (rs = 0.31; P = 0.024), but negatively with muscle fiber length (rs = -0.44; P = 0.001). We found no association between FGF19 and muscle thickness (P = 0.243). CONCLUSION: We highlighted in older patients significant correlations between FGF19 levels, pennation angle and muscle fiber length, suggesting that FGF19 could provide an enabling environment for the development of large muscle fibers, as previously suggested in histological studies in mice. However, high FGF-19 levels were unexpectedly associated with a low SPPB score. Further studies are needed to validate and further elucidate these exploratory findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FrailtySarcopeniaFemaleCross-Sectional StudiesHand StrengthMuscle Fibers, SkeletalMuscle, SkeletalHumansMaleAged, 80 and overAgedFibroblast Growth Factors

Stichwörter der Autor:innen

AgingFGF19SarcopeniaUltrasound

Substanzen

FGF19 protein, humanFibroblast Growth Factors

Autor:innen und Institutionen

  • Department of Gerontology, Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France. Electronic address: Emilie.bres@chu-lyon.fr.
  • Department of Gerontology, Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France.
  • Department of Biochemistry, Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France.
  • Department of Biostatistics, Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Pierre-Bénite, Cedex F-69495, France.
  • Department of Gerontology, Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France; Research on Healthcare professionals and Performance (RESHAPE, Inserm U1290), Université Claude Bernard Lyon1, Lyon…
  • Department of Gerontology, Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France; CarMeN Laboratory, INSERM U1060, INRA 1397, Université Claude Bernard Lyon 1, INSA Lyon, Oullins, France.

Zitieren

APA

Bres, E., Bouvier, J., Courtay, A., Delaire, L., Humblot, J., Cuerq, C., Tripoz-Dit-Masson, S., Fauvernier, M., Gilbert, T., & Bonnefoy, M. (2023). FGF19 and muscle architecture in older patients. Experimental Gerontology. https://doi.org/10.1016/j.exger.2023.112120

Vancouver

Bres E, Bouvier J, Courtay A, Delaire L, Humblot J, Cuerq C, et al. FGF19 and muscle architecture in older patients. Experimental Gerontology. 2023. doi:10.1016/j.exger.2023.112120

BibTeX
@article{Bres2023,
  author = {Bres, Emilie and Bouvier, Julia and Courtay, Aymeric and Delaire, Léo and Humblot, Joannes and Cuerq, Charlotte and Tripoz-Dit-Masson, Stéphanie and Fauvernier, Mathieu and Gilbert, Thomas and Bonnefoy, Marc},
  title = {FGF19 and muscle architecture in older patients},
  journal = {Experimental Gerontology},
  year = {2023},
  doi = {10.1016/j.exger.2023.112120}
}
Kostenlos starten →